πŸ›οΈ Verified NIH Record β€’ Updated 2025-11-04

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol (NCT07199309)

Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of MAR001 on Postprandial Lipids in Patients With Elevated Triglycerides and Remnant Cholesterol

🟒 Recruiting Phase2 πŸ’Š Investigational Drug / Biologic Sponsor: Marea Therapeutics

🩺 Plain-English Summary (8th-Grade Level)

The primary objective of the study is to determine the effect of MAR001 as compared to placebo on levels of the triglycerides (TG) in the postprandial state in adults with elevated TG.

Who can join: Review the eligibility criteria below.

Location: Marea Site 301 β€” Chula Vista, California

Age range: 18 Years to 75 Years

πŸ§ͺ Interventions in This Study

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (1 Sites)

  • Marea Site 301 β€” Chula Vista, California

πŸ“ž Contact the Study Coordinator

Phone: (415) 766-3610

Email: MAR-104-info@mareatx.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—